據報東方甄選(01797.HK)已註冊多個頓頓同名商標
東方甄選(01797.HK)宣布,頓頓不再擔任東方甄選主播,未來頓頓將作為東方甄選榮譽產品推薦官繼續和東方甄選合作。
被譽為「第二個董宇輝」的頓頓表示,與東方甄選的合約到期,覺得自己三十而立,想要挑戰更多未知的能力,在發展道路上繼續前行。
根據天眼查知識產權信息顯示,東方甄選旗下東方優選(北京)科技曾於2022年申請註冊「頓頓」及「王濤頓頓」商標,國際分類涉及皮革皮具、辦公用品、方便食品等,當前商標狀態均已註冊。此外,東方甄選還註冊多個「石明明明」、「孫楚涵悠悠」及「孫佳琦77」等文字及照片商標。據悉,石明與孫楚涵均為東方甄選主播。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.